Published research this week leans constructively bullish on US stocks over the cyclical horizon, even as a soft open is expected for the major indices and tactical caution runs alongside the optimism.
The bull case, as laid out by several strands of recent analyst commentary, rests on resilient earnings, solid GDP, policy support, and persistent buy-the-dip behavior. One camp flags that a real reassessment would only be triggered if the 10-year Treasury yield pushed well above 5%. A notably bolder published view targets the S&P 500 at 10,000, Nasdaq at 36,000, Russell 2000 at 4,000, and Dow at 70,000 this year — while warning of a roughly 80% collapse after the eventual blow-off top. These are framed as sequential scenarios, not contradictions. Strong equal-weight breadth is cited as a supporting signal.
At the sector level, researchers argue healthcare, software, energy, and gold miners look attractive, while a contrarian thread sees semiconductors vulnerable to an options-driven reversal. On single names, analysts flag Walmart for a 5–6% post-earnings drop and Moderna for profit-taking.